A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251 — Stella
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(17 sites)
United States
Retina-Vitreous Associates Medical Group, Beverly Hills, California
Retinal Consultants Medical Group, Sacramento, California
West Coast Retina, San Francisco, California
Retina Vitreous Associates of Florida, St. Petersburg, Florida
The Retina Care Center, Baltimore, Maryland
The Retina Institute, St Louis, Missouri
Sierra Eye Associates, Reno, Nevada
Duke Eye Center, Durham, North Carolina
Cincinnati Eye Institute, Blue Ash, Ohio
Mid Atlantic Retina, Philadelphia, Pennsylvania
Tennessee Retina PC, Nashville, Tennessee
Austin Clinical Research, LLC, Austin, Texas
Retina Consultants of Texas, Bellaire, Texas
Israel
Hadassah MC, Jerusalem
Tel Aviv Sourasky MC, Tel Aviv
Piedmont Eye Center, Lynchburg, Virginia
Spokane Eye Clinical Research;Spokane Eye Surgery Center, Spokane, Washington